The safety and effectiveness of donanemab – an Alzheimer’s drug recently approved by the US Food & Drug Administration (FDA) – is called into question in an investigation published by The BMJ today.
Concerns raised over safety and effectiveness of donanemab for Alzheimer’s treatment
The safety and effectiveness of donanemab - an Alzheimer's drug recently approved by the US Food & Drug Administration (FDA) - is called into question in an investigation published by The BMJ today.